Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

Circulation. 2021 Jul 20;144(3):e38-e39. doi: 10.1161/CIRCULATIONAHA.120.053057. Epub 2021 Jul 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Benzhydryl Compounds / adverse effects
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucosides
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Humans
  • Prediabetic State*
  • Stroke Volume

Substances

  • Benzhydryl Compounds
  • Glucosides
  • empagliflozin